DocGo Inc. Form 8-K Summary
Business Context and Reporting Period
DocGo Inc. filed a Form 8-K dated May 8, 2023, under Item 2.02 to announce the issuance of earnings results for the quarter ended March 31, 2023. The filing references a related May 8, 2023 press release furnished as Exhibit 99.1, but the press release text and financial results are not included in the provided filing content.
Financial Metrics
The provided filing text does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, operating expenses, or other financial metrics. These details may be contained in Exhibit 99.1, which is referenced but not reproduced here.
Material Changes Versus Prior Comparable Period
The filing does not provide quantitative or qualitative comparisons with the quarter ended March 31, 2022 or any other prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the provided filing text. The filing states that the Item 2.02 information and attached exhibit are furnished and are not deemed filed for purposes of the Exchange Act, nor incorporated by reference into other filings, except where expressly specified.
Key Facts to Verify
- Obtain and review Exhibit 99.1 for the complete quarterly earnings release and financial metrics.
- Verify DocGo’s reported revenue, profitability, cash flow, margins, balance-sheet liquidity, and debt for the quarter ended March 31, 2023.
- Review any year-over-year comparisons, guidance, outlook, non-GAAP measures, and reconciliation disclosures in the earnings release.
- Confirm the filing date of May 8, 2023 and that the report was signed by Norman Rosenberg, Chief Financial Officer.